1. Home
  2. NMAI vs LAB Comparison

NMAI vs LAB Comparison

Compare NMAI & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Multi-Asset Income Fund of Beneficial Interest

NMAI

Nuveen Multi-Asset Income Fund of Beneficial Interest

HOLD

Current Price

$13.00

Market Cap

461.6M

Sector

Finance

ML Signal

HOLD

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.99

Market Cap

488.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMAI
LAB
Founded
2021
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
461.6M
488.4M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
NMAI
LAB
Price
$13.00
$0.99
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$1.35
AVG Volume (30 Days)
107.8K
2.0M
Earning Date
01-01-0001
05-18-2026
Dividend Yield
13.14%
N/A
EPS Growth
N/A
44.68
EPS
0.64
N/A
Revenue
N/A
$101,937,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.63
P/E Ratio
$20.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.21
$0.92
52 Week High
$13.96
$1.72

Technical Indicators

Market Signals
Indicator
NMAI
LAB
Relative Strength Index (RSI) 31.37 26.69
Support Level $12.72 $0.97
Resistance Level $13.05 $1.41
Average True Range (ATR) 0.18 0.07
MACD -0.09 -0.01
Stochastic Oscillator 6.82 4.14

Price Performance

Historical Comparison
NMAI
LAB

About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest

Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Share on Social Networks: